News

ORNL researcher Louise Evans is working to ensure safeguards approaches and verification technologies are integrated early in the design process of advanced reactor technologies. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy
Decades of nuclear expertise guides global nonproliferation innovation
To turn carbon dioxide, or CO2, into methanol, or CH3OH, copper (shown in yellow) on a hydride-substituted support speeds reactions mediated by hydrides and catalyzed by hydrogen atoms (shown in black) from surface-adsorbed formate, HCOO*. Credit: Yang He/ORNL, U.S. Dept. of Energy
Ion swap improves CO2-defeating catalyst
Caption: The Na-CO2 battery developed at ORNL, consisting of two electrodes in a saltwater solution, pulls atmospheric carbon dioxide into its electrochemical reaction, and releases only valuable biproducts. Credit: Andy Sproles/ORNL, U.S. Dept. of Energy
Carbon-capture batteries store renewable energy

Filter News

Area of Research

News Type

Date

News Topics

Media Contacts

Connect with ORNL

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy

DOE scientists deploy creativity, speed to disrupt COVID-19

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.

ATOM logo

Oak Ridge National Laboratory joins ATOM Consortium to Accelerate Drug Discovery

The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.